Skip to main content
logo
Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.1850
0.00 (0.00%)
At close: Aug 4, 2025

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 NaN - NaN
Contract Development Manufacture Organisation and Commercialisation
1.27B
Log In
Log In
Log In
Log In
Upgrade
Contract Development Manufacture Organisation and Commercialisation Growth
-11.98%
Log In
Log In
Log In
Log In
Upgrade
Drug Discovery
859.61M
Log In
Log In
Log In
Log In
Upgrade
Drug Discovery Growth
-7.92%
Log In
Log In
Log In
Log In
Upgrade
Viva BioInnovator
19.62M
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 NaN - NaN
United States
862.86M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-3.93%
Log In
Log In
Log In
Log In
Upgrade
European Union
675.83M
Log In
Log In
Log In
Log In
Upgrade
European Union Growth
3.74%
Log In
Log In
Log In
Log In
Upgrade
China
289.73M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-18.99%
Log In
Log In
Log In
Log In
Upgrade
Other Asian Countries
209.82M
Log In
Log In
Log In
Log In
Upgrade
Other Asian Countries Growth
-34.83%
Log In
Log In
Log In
Log In
Upgrade
Other Countries/Regions
66.64M
Log In
Log In
Log In
Log In
Upgrade
Other Countries/Regions Growth
-35.25%
Log In
Log In
Log In
Log In
Upgrade
Africa
49.08M
Log In
Log In
Log In
Log In
Upgrade
Africa Growth
-1.36%
Log In
Log In
Log In
Log In
Upgrade